INRoads to researching liver disease and coagulation
Posted on: April 29, 2021
This is an archived edition of our email newsletter.
It’s Not Just Support. It’s Solutions.
DiaPharma has the tools for your Liver Disease Coagulopathy Research
Markers of Hemostasis
Liver diseases such as acute fatty liver or cirrhosis can be associated with imbalances in coagulation, whether due to defects of platelet count/function, decrease in synthesis of coagulation factors, decrease in clearance of activated coagulation factors, or overactive fibrinolysis.
Research may focus on answering questions such as which subjects are bleeding risks? Which may have thrombotic complications? What is the severity of the liver disease? Do you need more information than the INR can give?
If you’re studying intrahepatic thrombosis, liver fibrogenesis, or developing new hemostasis-focused liver disease therapies, DiaPharma can help you select the assays that best suit your needs.
DiaPharma’s long-time expertise in the Hemostasis and Liver Disease fields means we’re uniquely positioned to deliver solutions.
Technothrombin® TGA*
- Give thrombotic potential a number. Research thrombin generation when studying disease and progression
- Automatable on the Ceveron® s100 or t100
Fibrinolytic Markers*
- PAI-1 Activity and Antigen, Plamsin-Antiplasmin (P-AP) ELISAs
Bleeding Disorder Markers
- vWF activity, vWFantigen, vWF propeptide, collagen binding* ELISAs
T-TAS01® Platelet Function Analyzer
- Discover the leading edge in primary hemostasis assessment
- Global evaluation of overall hemostatic ability in whole blood, using physiologic, flow conditions
- Easy interpretation, reduced costs, simple pre-analytics
Non-Invasive Biomarkers for Fatty Liver Disease*
- CK18 and ccCK18 cell death biomarkers for liver disease
- Measure apoptosis (M30®) or total cell death (M65®)
Visit diapharma.com for our portfolio of biomarker assays for Complement, Bleeding Disorders, and Fibrinolysis
*Research use only in the U.S. and Canada. Not for use in diagnostic procedures.
COVID-19 and Coagulation Research
Studying coagulation in COVID-19? Explore assays from DiaPharma to answer your COVID-19 research questions.
It’s Not Just Support. It’s Solutions.
Over 20 years of scientific expertise, with support just a call or click away.
DiaPharma Group, Inc., 8948 Beckett Rd, West Chester, OH 45069
Technical Support: 1.800.447.3846
ML-00-00804Rev01